Goldman Sachs Group Inc. cut its position in shares of Perrigo Company plc (NYSE:PRGO) by 5.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,090,031 shares of the company’s stock after selling 130,899 shares during the quarter. Goldman Sachs Group Inc. owned 1.48% of Perrigo worth $182,166,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in PRGO. Dupont Capital Management Corp bought a new position in shares of Perrigo in the fourth quarter valued at approximately $104,000. ARP Americas LP bought a new position in shares of Perrigo in the fourth quarter valued at approximately $212,000. Quantitative Systematic Strategies LLC bought a new position in shares of Perrigo in the fourth quarter valued at approximately $213,000. V Wealth Management LLC bought a new position in shares of Perrigo in the fourth quarter valued at approximately $214,000. Finally, Investors Research Corp bought a new position in Perrigo in the 4th quarter worth approximately $214,000. 79.01% of the stock is currently owned by institutional investors and hedge funds.
Perrigo Company plc (NYSE PRGO) opened at $84.95 on Monday. Perrigo Company plc has a fifty-two week low of $63.68 and a fifty-two week high of $95.93. The stock has a market cap of $11,963.81, a price-to-earnings ratio of 17.20, a PEG ratio of 1.96 and a beta of 0.82. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.96 and a quick ratio of 1.40.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 2nd will be paid a $0.19 dividend. The ex-dividend date is Thursday, March 1st. This is a positive change from Perrigo’s previous quarterly dividend of $0.16. This represents a $0.76 dividend on an annualized basis and a yield of 0.89%. Perrigo’s dividend payout ratio is presently 90.48%.
Several research analysts recently weighed in on PRGO shares. Cantor Fitzgerald set a $107.00 price objective on shares of Perrigo and gave the stock a “buy” rating in a research report on Wednesday, November 15th. Barclays boosted their price objective on shares of Perrigo to $93.00 and gave the stock an “overweight” rating in a research report on Monday, December 4th. Argus upgraded shares of Perrigo from a “hold” rating to a “buy” rating and set a $93.00 price objective for the company in a research report on Friday, December 8th. Canaccord Genuity set a $100.00 target price on shares of Perrigo and gave the stock a “buy” rating in a report on Tuesday, December 26th. Finally, Leerink Swann started coverage on shares of Perrigo in a report on Tuesday, January 2nd. They set a “market perform” rating and a $90.00 target price for the company. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have given a buy rating to the stock. Perrigo presently has an average rating of “Hold” and an average target price of $91.88.
In other Perrigo news, VP Todd W. Kingma sold 1,500 shares of the business’s stock in a transaction dated Thursday, December 28th. The shares were sold at an average price of $88.52, for a total transaction of $132,780.00. Following the sale, the vice president now directly owns 19,565 shares of the company’s stock, valued at approximately $1,731,893.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Uwe Roehrhoff purchased 7,500 shares of the business’s stock in a transaction on Monday, March 5th. The shares were acquired at an average cost of $81.85 per share, for a total transaction of $613,875.00. Following the completion of the transaction, the chief executive officer now directly owns 4,900 shares in the company, valued at $401,065. The disclosure for this purchase can be found here. 6.90% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “Goldman Sachs Group Inc. Sells 130,899 Shares of Perrigo Company plc (PRGO)” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2018/03/12/goldman-sachs-group-inc-sells-130899-shares-of-perrigo-company-plc-prgo.html.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.